Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae

Cell

Volumn 89, Issue 5, 1997, Pages 811-819

  Glover, John R ^a   Kowal, Anthony S ^a   Schirmer, Eric C ^a   Patino, Maria M ^a   Liu, Jia Jia ^a   Lindquist, Susan ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CONGO RED; PRION PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CYTOSOL; DIAGNOSTIC VALUE; ESCHERICHIA COLI; INHERITANCE; NONHUMAN; PHENOTYPE; POLYMERIZATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 0030712145     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80264-0     Document Type: Article

References (42)

1. Akasura, S. (1970). Polymerization of flagellin and polymorphism of flagella. Adv. Biophys. 1, 99-155.
2. Bessen, R.A. and Marsh, R.F. (1994). Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68, 7858-7868.
3. Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, S., Lansbury, P.T., and Caughey, B. (1995). Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700.
4. Caughey, B., and Chesebro, B. (1997). Prion protein and the trans-missible spongiform encephalopathies. Trends Cell Biol. 7, 56-62.
5. Caughey, B., Kocisko, D.A., Raymond, G.J., and Lansbury, P.T., Jr. (1995). Aggregates of scrapie associated prion protein induce the cell free conversion of protease-sensitive prion protein to the protease-resistant state. Chem. Biol. 2, 807-817.
6. Chernoff, Y.O., Derkatch, I.L., and Inge-Vechtomov, S.G. (1993). Multicopy SUP35 gene induces de novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 24, 268-270.
7. +]. Science 268, 880-884.
8. Clos, J. and Brandau, S. (1994). pJC20 and pJC40 - two high-copy-number vectors for T7 RNA polymerase-dependent expression of recombinant genes in Escherichia coli. Prot. Exp. Purif. 5, 133-137.
9. Come, J.H., Fraser, P.E., and Lansbury, P.T., Jr. (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. USA 90, 5959-5963.
10. Cox, B.S. (1965). ψ, a cytoplasmic suppressor of super-suppression in yeast. Heredity 20, 505-521.
11. Cox, B.S., Tuite, M.F., and McLaughlin, C.S. (1988). The psi factor of yeast: a problem of inheritance. Yeast 4, 159-178.
12. Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov, S.G., and Liebman, S.W. (1996). Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375-1386.
13. Didichenko, S.A., Ter-Avanesyan, M.D., and Smirnov, V.N. (1991). Ribosome-bound EF1α-like protein of yeast Saccharomyces cerevisiae. Eur. J. Biochem. 198, 705-711.
14. Doel, S.M., McCready, S.J., Nierras, C.R., and Cox, B.S. (1994). The dominant PNM2 - mutation that eliminates the ψ factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137, 659-670.
15. Harper, J.D., Wong, S.S., Lieber, C.M., and Lansbury, P.T., Jr. (1997). Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
16. Horwich, A.L. and Weissman, J.S. (1997). Deadly conformations - protein misfolding in prion disease. Cell 89, 499-510.
17. Jarret, J.T., and Lansbury, P.T., Jr. (1993). Seeding "one dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
18. Jarret, J.T., Berger, E.P., and Lansbury, P.T., Jr. (1993). The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
19. Kelly, J.W. (1996). Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6, 11-17.
20. Klunk, W.E., Pettegrew, J.W., and Abraham, D.J. (1989). Two simple methods for quantitating low affinity dye-substrate binding. J. Hystochem. Cytochem. 37, 1293-1279.
21. Kushnirov, V.V., Ter-Avanesyan, M.D., Didichenko, S.A., Smirnov, V.N., and Chernoff, Y.O. (1990). Divergence and conservation of SUP2 (SUP35) gene of yeasts Pichia pinus and Saccharomyces cerevisiae. Yeast 6, 461-472.
22. Lansbury, P.T., Jr., and Caughey, B. (1995). The chemistry of scrapie infection: the 'ice 9' metaphor. Chem. Biol. 2, 1-5.
23. Lindquist, S. (1997). Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell 89, 495-498.
24. Nesloney, C.L., and Kelly, J.W. (1996). Progress toward understanding β-sheet structure. Bioorganic Med. Chem. 4, 739-766.
25. Parsell, D.A., Kowal, A.S., Singer, M.A., and Lindquist, S. (1994). Protein disaggregation mediated by heat-shock protein Hsp 104. Nature 372, 475-478.
26. Patino, M.M., Liu, J.J.,Glover, J.R., and Lindquist, S. (1996). Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622-626.
27. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. (1996). Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15, 3127-3134.
28. Paushkin, S.V., Krusnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. (1997). Interaction between yeast Sup45p (eRF1)and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol. Cell. Biol. 17, 2798-2805.
29. Prusiner, S.B. (1994). Biology and genetics of prion diseases. Annu. Rev. Microbiol. 48, 655-658.
30. Sambrook, J., Fritsch, E.E., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory).
31. Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Walchli, M.,Torchia, M., Groth, D.,Carlson,G., DeArmond, S.J., and Prusiner, S.B. (1989).Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847-857.
32. Sherman, F., Fink, G.R., and Hicks, J.B. (1986). Manual for Methods in Yeast Genetics (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory).
33. Sikorski, R.S., and Hieter, P. (1989). A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122, 19-27.
34. Sipe, J.D. (1994). Amyloidosis. Crit. Rev. Clin. Lab. Sci. 31, 325-354.
35. Spiess, E., Zimmerman, H.P., and Lunsdorf, H. (1987). In Electron Microscopy in Molecular Biology: A Practical Approach, J. Sommerville and U. Scheer, eds. (Oxford: IRL Press Ltd.), pp. 147-166.
36. Stansfield, I., and Tuite, M.F. (1994). Polypeptide chain termination in Saccharomyces cerevisiae. Curr. Genet. 25, 385-395.
37. Stansfield, I., Jones, K.M., Kushnirov, V.V., Dagkesamanskaya, A.R., and Poznyakovski, A.I. (1995). The products of the SUP45 (eRF1) and SUP35genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 14, 4365-4373.
38. Ter-Avanesyan, M.D., Kushnirov, V.V., Dagkesamanskaya, A.R., Didchenko, S.A., and Chernoff, Y.O. (1993). Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683-692.
39. Ter-Avanesyan, M.D., Dagkesamanskaya, A.R., Kushnirov, V.V., and Smirnov, V.N. (1994). The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137, 671-676.
40. Thiele, D.J. (1988). ACE1 regulates expression of the Saccharomyces cerevisiae metallothionein gene. Mol. Cell. Biol. 8, 2745-2752.
41. Wickner, R.B. (1994). [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566-569.
42. Zhouravleva, G., Frolova, L., Legoff, X., Leguellec, R., and Inge-Vechtomov, G. (1995). Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J. 14, 4065-4072.